Attendee Breakdown
This summit is designed for CNS leaders driving a new generation of CNS-targeted therapies.
Explore the full breakdown and see who's in the room.
Job Titles
Chief Executive Officers • Chief Scientific Officers • Chief Development Officers • Chief Financial Officers • Executive Vice Presidents • Senior Vice Presidents • Vice Presidents • Heads of Research • Heads of Business Development • Drug Development Leaders • Senior Directors • Directors • Principal Scientists • Senior Scientists
Organisations
AbbVie • ABL Bio • Angelini Pharma • AriBio • Biorchestra • Eli Lilly and Company • H. Lundbeck • Johnson & Johnson • JCR Pharmaceuticals • Medincell • Mthera Pharma • Novartis • Novorex • Rznomics • Sanofi • Shaperon • Takeda Pharmaceuticals • Zincure
Explore the Full Event Guide
공식 아젠다를 다운로드하여 다음 내용을 확인하세요
- Cutting-edge insights from pioneering Korean innovators, alongside voices from Japan, China, US, India and Europe
- Presentations containing new data from AriBio, Mthera Pharma, ADEL, JCR Pharmaceuticals, Genuv and more
- Dedicated networking opportunities with global experts working on neurodegenerative, rare neurodevelopmental, and neuropsychiatric disorders
- Strategic investment insights from global representatives at Novartis, Takeda, Eli Lilly, Johnson & Johnson and more
Explore the Agenda
Hear the latest CNS innovations taking place within South Korea while hearing from global experts.
Partner With Us
Position yourself alongside other leading solution providers to ensure your company is the go-to service providers for Korean neuroscience drug developers.
Join Biopharma Experts
Be part of the hottest conversations with like-minded neuroscientists, C-level executives, heads, VPs, and more across discovery, translational and clinical development.